Blood Tests for Multiple Sclerosis: The Role of NfL and GFAP Biomarkers
Multiple sclerosis (MS) research has increasingly focused on blood-based biomarkers to track disease activity, with recent clinical evaluations centering on neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP). While NfL levels reflect acute axonal damage and nerve fiber injury, investigators examine GFAP as an indicator of chronic neuroinflammation and glial scarring associated with … Read more